These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30723583)

  • 21. Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254).
    Kraus VB; Birmingham J; Stabler TV; Feng S; Taylor DC; Moorman CT; Garrett WE; Toth AP
    Osteoarthritis Cartilage; 2012 Apr; 20(4):271-8. PubMed ID: 22273632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-1 receptor antagonist (IL-1Ra) is more effective in suppressing cytokine-induced catabolism in cartilage-synovium co-culture than in cartilage monoculture.
    Mehta S; Akhtar S; Porter RM; Önnerfjord P; Bajpayee AG
    Arthritis Res Ther; 2019 Nov; 21(1):238. PubMed ID: 31722745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 receptor antagonist correlates with hepatic venous pressure gradient and predicts occurrence of overall complications and bacterial infections in patients with cirrhosis.
    Hsieh YC; Lee KC; Yang YY; Huo TI; Huang YH; Lin HC
    Hepatol Res; 2015 Mar; 45(3):294-304. PubMed ID: 24826996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated serum interleukin-1β levels and interleukin-1β-to-interleukin-1 receptor antagonist ratio 1 week after embryo transfer are associated with ectopic pregnancy.
    Lekovich J; Witkin SS; Doulaveris G; Orfanelli T; Shulman B; Pereira N; Rosenwaks Z; Spandorfer SD
    Fertil Steril; 2015 Nov; 104(5):1190-4. PubMed ID: 26279136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 receptor antagonist treatment in acute ischaemic stroke does not alter systemic markers of anti-microbial defence.
    McCulloch L; Allan SM; Emsley HC; Smith CJ; McColl BW
    F1000Res; 2019; 8():1039. PubMed ID: 31700615
    [No Abstract]   [Full Text] [Related]  

  • 26. Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.
    Opal SM; Fisher CJ; Dhainaut JF; Vincent JL; Brase R; Lowry SF; Sadoff JC; Slotman GJ; Levy H; Balk RA; Shelly MP; Pribble JP; LaBrecque JF; Lookabaugh J; Donovan H; Dubin H; Baughman R; Norman J; DeMaria E; Matzel K; Abraham E; Seneff M
    Crit Care Med; 1997 Jul; 25(7):1115-24. PubMed ID: 9233735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracerebroventricular injection of interleukin-1 stimulates the release of high levels of interleukin-6 and interleukin-1 receptor antagonist into peripheral blood in the primate.
    Xiao E; Xia L; Ferin M; Wardlaw SL
    J Neuroimmunol; 1999 Jun; 97(1-2):70-6. PubMed ID: 10408981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets.
    Hui Q; Asadi A; Park YJ; Kieffer TJ; Ao Z; Warnock GL; Marzban L
    Mol Metab; 2017 Aug; 6(8):833-844. PubMed ID: 28752047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Counter-regulation of interleukin-1alpha (IL-1alpha) and IL-1 receptor antagonist in murine keratinocytes.
    Mee JB; Antonopoulos C; Poole S; Kupper TS; Groves RW
    J Invest Dermatol; 2005 Jun; 124(6):1267-74. PubMed ID: 15955103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-1 receptor antagonist inhibits growth modulation of human tumor-cell lines by interleukin-1 in-vitro.
    Oelmann E; Topp M; Reufi B; Papadimitriou C; Koenigsmann M; Oberberg D; Thiel E; Berdel W
    Int J Oncol; 1994 Mar; 4(3):555-8. PubMed ID: 21566958
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies.
    Gottsäter A; Forsblad J; Mätzsch T; Persson K; Ljungcrantz I; Ohlsson K; Lindgärde F
    J Intern Med; 2002 Jan; 251(1):61-8. PubMed ID: 11851866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group.
    Fisher CJ; Dhainaut JF; Opal SM; Pribble JP; Balk RA; Slotman GJ; Iberti TJ; Rackow EC; Shapiro MJ; Greenman RL
    JAMA; 1994 Jun; 271(23):1836-43. PubMed ID: 8196140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Rectus Sheath Block Analgesia Reduce the Inflammatory Response Biomarkers' IL-1ra, IL-6, IL-8, IL-10 and IL-1β Concentrations Following Surgery? A Randomized Clinical Trial of Patients with Cancer and Benign Disease.
    Purdy M; Kokki M; Anttila M; Aspinen S; Juvonen P; Korhonen R; Selander T; Kokki H; Eskelinen M
    Anticancer Res; 2016 Jun; 36(6):3005-11. PubMed ID: 27272818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
    van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
    Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graves' ophthalmopathy and gene polymorphisms in interleukin-1alpha, interleukin-1beta, interleukin-1 receptor and interleukin-1 receptor antagonist.
    Khalilzadeh O; Anvari M; Esteghamati A; Mahmoudi M; Tahvildari M; Rashidi A; Khosravi F; Amirzargar A
    Clin Exp Ophthalmol; 2009 Aug; 37(6):614-9. PubMed ID: 19702713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute-phase responses in transgenic mice with CNS overexpression of IL-1 receptor antagonist.
    Lundkvist J; Sundgren-Andersson AK; Tingsborg S; Ostlund P; Engfors C; Alheim K; Bartfai T; Iverfeldt K; Schultzberg M
    Am J Physiol; 1999 Mar; 276(3):R644-51. PubMed ID: 10070123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin 6 and interleukin 1 receptor antagonist as early markers of complications after lung cancer surgery.
    Szczesny TJ; Slotwinski R; Stankiewicz A; Szczygiel B; Zaleska M; Kopacz M
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):719-24. PubMed ID: 17317198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pre-interleukin-1alpha expression reduces cell growth and increases interleukin-6 production in SaOS-2 osteosarcoma cells: Differential inhibitory effect of interleukin-1 receptor antagonist (icIL-1Ra1).
    Palmer G; Trolliet S; Talabot-Ayer D; Mézin F; Magne D; Gabay C
    Cytokine; 2005 Jul; 31(2):153-60. PubMed ID: 15923123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin 1 and receptor antagonist levels in gingival crevicular fluid in heavy smokers versus non-smokers.
    Rawlinson A; Grummitt JM; Walsh TF; Ian Douglas CW
    J Clin Periodontol; 2003 Jan; 30(1):42-8. PubMed ID: 12702110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.